VASCULAR WALL HYPERTROPHY

This adverse event was reported 56 times

These drugs are most commonly taken by patients reporting VASCULAR WALL HYPERTROPHY:

# Drug Count
0 ASPIRIN 6
1 ASPIRIN 325 MG 6
2 ASPIRIN 81 MG 6
3 TACROLIMUS 6
4 TACROLIMUS EXTENDED-RELEASE CAPSULES 6
5 TACROLIMUS OINTMENT 0.1% 6
6 METHOTREXATE 5
7 METHOTREXATE SODIUM 5
8 PREDNISONE 5
9 ADALIMUMAB 4
See all common drugs associated with VASCULAR WALL HYPERTROPHY

VASCULAR WALL HYPERTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TESTOSTERONE ENANTHATE 1 0.0006
1 BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES 1 0.0006
2 TESTOSTERONE UNDECANOATE 1 0.0005
3 ETRAVIRINE 2 0.0005
4 NITRIC OXIDE 2 0.0004
5 THIOTEPA 4 0.0004
6 BARICITINIB 1 0.0003
7 ABACAVIR SULFATE 3 0.0003
8 BROLUCIZUMAB 1 0.0003
9 BASILIXIMAB 3 0.0003
See all drugs enriched for association with VASCULAR WALL HYPERTROPHY